Chemoprevention refers to the use of pharmaceuticals to mitigate cancer occurrence; for breast cancer, selective estrogen receptor modulators (e.g., tamoxifen, raloxifene) and aromatase inhibitors (e.g., anastrozole, exemestane) have been the most promising [30,31,32,33,34]. This evidence concerns the gene ESR1 and breast cancer.